Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	BHLHE41 CUX2 HIVEP2 IRX5 MYT1 ZNF229 GTF2IRD1 LHX6 ZNF623 MEF2C ZNF2 HOXA7 HOXA10 ZNF430 SP8 ZNF19 ZNF610 ZBTB39 HOXC11 NFIA NFATC3 ZNF425 DBX1 ZNF431 LHX5 ZNF528 ZNF417 ZNF614 NOTCH4 PRRX2	1.47e-05	1412	184	30	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	BHLHE41 CUX2 HIVEP2 IRX5 MYT1 NSD1 ZNF229 GTF2IRD1 LHX6 ZNF623 MEF2C ZNF2 HOXA7 HOXA10 ZNF430 SP8 ZNF19 ZNF610 ZBTB39 HOXC11 NFIA NFATC3 ZNF425 ZNF431 LHX5 ZNF528 ZNF417 ZNF614 PRRX2	6.97e-05	1459	184	29	GO:0000977
Domain	EGF	ATRN DLL1 ITGB5 NRXN3 CELSR2 NRXN2 LRP4 LTBP1 NOTCH4	3.51e-06	126	179	9	PF00008
Domain	EGF_1	ATRN DLL1 ITGB5 NRXN3 FBN2 TENM4 CELSR2 NRXN2 PRF1 LRP4 LTBP1 NOTCH4	6.69e-06	255	179	12	PS00022
Domain	EGF-like_CS	ATRN DLL1 ITGB5 NRXN3 FBN2 TENM4 CELSR2 NRXN2 PRF1 LRP4 LTBP1 NOTCH4	8.47e-06	261	179	12	IPR013032
Domain	EGF_2	ATRN DLL1 ITGB5 NRXN3 FBN2 TENM4 CELSR2 NRXN2 PRF1 LRP4 LTBP1 NOTCH4	9.88e-06	265	179	12	PS01186
Domain	EGF	ATRN DLL1 ITGB5 NRXN3 FBN2 TENM4 CELSR2 NRXN2 LRP4 LTBP1 NOTCH4	1.72e-05	235	179	11	SM00181
Domain	EGF_3	ATRN DLL1 NRXN3 FBN2 TENM4 CELSR2 NRXN2 PRF1 LRP4 LTBP1 NOTCH4	1.72e-05	235	179	11	PS50026
Domain	EGF-like_dom	ATRN DLL1 NRXN3 FBN2 TENM4 CELSR2 NRXN2 PRF1 LRP4 LTBP1 NOTCH4	2.93e-05	249	179	11	IPR000742
Domain	ASX_HYDROXYL	DLL1 NRXN3 FBN2 CELSR2 LRP4 LTBP1 NOTCH4	4.99e-05	100	179	7	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	DLL1 NRXN3 FBN2 CELSR2 LRP4 LTBP1 NOTCH4	7.25e-05	106	179	7	IPR000152
Domain	Homeobox_CS	CUX2 IRX5 LHX6 HOXA7 HOXA10 HOXC11 DBX1 LHX5 PRRX2	7.87e-05	186	179	9	IPR017970
Domain	hEGF	DLL1 FBN2 CELSR2 NOTCH4	1.40e-04	28	179	4	PF12661
Domain	Homeobox	CUX2 IRX5 LHX6 HOXA7 HOXA10 HOXC11 DBX1 LHX5 PRRX2	4.38e-04	234	179	9	PF00046
Domain	HOMEOBOX_1	CUX2 IRX5 LHX6 HOXA7 HOXA10 HOXC11 DBX1 LHX5 PRRX2	4.66e-04	236	179	9	PS00027
Domain	HOX	CUX2 IRX5 LHX6 HOXA7 HOXA10 HOXC11 DBX1 LHX5 PRRX2	4.80e-04	237	179	9	SM00389
Domain	HOMEOBOX_2	CUX2 IRX5 LHX6 HOXA7 HOXA10 HOXC11 DBX1 LHX5 PRRX2	5.10e-04	239	179	9	PS50071
Domain	Homeobox_dom	CUX2 IRX5 LHX6 HOXA7 HOXA10 HOXC11 DBX1 LHX5 PRRX2	5.10e-04	239	179	9	IPR001356
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLNC SHROOM3 HIVEP2 NSD1 KDM3B GTF2IRD1 DLL1 ITGB5 PLEKHM1 MAP3K5 MAPK8IP3 SH3BP4 JAK2 SCAF1 FAM20C MROH1 CELSR2 PROM2 CASKIN1 LRP4 PCNX1 HMGXB3 SMURF2 ZNF614 TRAPPC9	1.36e-09	1105	186	25	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 SHROOM3 MCMBP HIVEP2 RAB11FIP2 USP43 KDM3B KLC2 GSK3A LUZP1 MEX3C SH3BP4 CDCA2 MAST4 NFATC3 SH3D19 MTCL1 CRYBG3 RNF180 TRAPPC9 BICC1	8.64e-09	861	186	21	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATRN FLNB SHROOM3 HIVEP2 RASA1 MYT1 HIPK2 TNRC6B GTF2IRD1 CEP43 ITGB5 PLEKHM1 MAPK8IP3 SH3BP4 JAK2 EXD3 ANAPC10 NFIA KCND3 PROM2 VPS41 CDK5RAP1 OS9 ZNF528 SMURF2 TRAPPC9	1.17e-07	1489	186	26	28611215
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MPP2 KCTD9 ARHGAP32 DMXL2 SHROOM3 NSD1 TNRC6B GRM1 GRM4 LUZP1 MAP3K5 MAPK8IP3 FRY RACK1 CELSR2 NFATC3 CASKIN1 SH3D19 PLCL1 MTCL1	2.67e-07	963	186	20	28671696
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MPP2 FLNB FLNC ARHGAP32 DMXL2 IL16 KLC2 GRM1 AP3M1 LUZP1 MAPK8IP3 TENM4 GRK2 RACK1 LRIG1 NRXN2 KCND3 CASKIN1 PLCL1 PRDX5 CORO7 SNRNP200 TRAPPC9 RPL18	7.72e-07	1431	186	24	37142655
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	CUX2 HIVEP2 MYT1 BAZ1B ID4 GTF2IRD1 MEF2C MEX3C RFPL4AL1 HOXA10 RFPL4A NFIA HMGXB3 LHX5 PRDX5 RNF180	1.54e-06	709	186	16	22988430
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	LRP12 SHROOM3 FBN2 TENM4 CRYBG3 SPINK5	2.32e-06	71	186	6	33541421
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	IPPK ATRN FLNB MCMBP BMS1 ID4 LRRC40 SLFN5 RBM28 IGSF10 JAK2 SCAF1 FAM20C FRY MTCL1 SNRNP200	2.49e-06	736	186	16	29676528
Pubmed	Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.	FLT3 RASA1 JAK2	5.19e-06	7	186	3	19773259
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL6A3 ITGA6 ITGA1 ITGB5 FBN2	7.23e-06	50	186	5	23658023
Pubmed	ST7 is a novel low-density lipoprotein receptor-related protein (LRP) with a cytoplasmic tail that interacts with proteins related to signal transduction pathways.	LRP12 ZFYVE9 RACK1	8.26e-06	8	186	3	12809483
Pubmed	Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways.	CUX2 ID4 LHX6 MEF2C SP8 NRXN3 DBX1	8.28e-06	134	186	7	19030180
Pubmed	A census of human transcription factors: function, expression and evolution.	BHLHE41 CUX2 HIVEP2 IRX5 MYT1 ID4 LHX6 MEF2C HOXA7 ZNF19 HOXC11 WDHD1 NFIA NFATC3 DBX1 LHX5 PRRX2	8.62e-06	908	186	17	19274049
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MPP2 FLNB ARHGAP32 DMXL2 RAB11FIP2 KLC2 TNRC6B AP3M1 GSK3A MAPK8IP3 TENM4 GRK2 MECR RACK1 CELSR2 KCND3 CASKIN1 CRYBG3 PRDX5	1.28e-05	1139	186	19	36417873
Pubmed	The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma.	FLNB FLNC TNRC6B	1.76e-05	10	186	3	36357400
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNRC6B CEP43 GSK3A LUZP1 SPAG5 MAST4 MTCL1 CRYBG3	1.82e-05	209	186	8	36779422
Pubmed	The doublesex homolog Dmrt5 is required for the development of the caudomedial cerebral cortex in mammals.	CUX2 GRIK4 SP8 DBX1 LHX5	2.27e-05	63	186	5	22923088
Pubmed	Mouse endothelial OTUD1 promotes angiotensin II-induced vascular remodeling by deubiquitinating SMAD3.	FLNB FLNC RACK1	2.41e-05	11	186	3	36579465
Pubmed	NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1.	ID4 GRIK4 DLL1 NFIA	2.53e-05	32	186	4	20610746
Pubmed	MCMBP promotes the assembly of the MCM2-7 hetero-hexamer to ensure robust DNA replication in human cells.	MCMBP MCM2	2.84e-05	2	186	2	35438632
Pubmed	Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression.	RACK1 SMURF2	2.84e-05	2	186	2	37828084
Pubmed	Neutrophil-derived glutamate regulates vascular endothelial barrier function.	GRM1 GRM4	2.84e-05	2	186	2	11847215
Pubmed	m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways.	ITGA6 HOXA10	2.84e-05	2	186	2	38369001
Pubmed	Selenoprotein P, peroxiredoxin-5, renalase, and total antioxidant status in patients with suspected obstructive sleep apnea.	SELENOP PRDX5	2.84e-05	2	186	2	37495908
Pubmed	A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha.	FLNB FLNC	2.84e-05	2	186	2	9694715
Pubmed	MEX3C promotes osteosarcoma malignant progression through negatively regulating FGF14.	MEX3C FGF14	2.84e-05	2	186	2	32862604
Pubmed	[JAK2-V617F mutation in patients with myeloproliferative neoplasms: association with FLT3-ITD mutation].	FLT3 JAK2	2.84e-05	2	186	2	21180092
Pubmed	Phosphorylation-independent regulation of metabotropic glutamate receptor 1 signaling requires g protein-coupled receptor kinase 2 binding to the second intracellular loop.	GRM1 GRK2	2.84e-05	2	186	2	15870073
Pubmed	FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of Heterozygosity.	FLT3 JAK2	2.84e-05	2	186	2	28108507
Pubmed	Absence of FLT3 and JAK2 (V617F) mutations in Langerhans cell histiocytosis.	FLT3 JAK2	2.84e-05	2	186	2	19395028
Pubmed	The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.	PODXL ITGA6	2.84e-05	2	186	2	18818395
Pubmed	The limits of promiscuity: isoform-specific dimerization of filamins.	FLNB FLNC	2.84e-05	2	186	2	12525170
Pubmed	Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy.	GRM1 GRM4	2.84e-05	2	186	2	17446080
Pubmed	Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.	FLT3 NOTCH4	2.84e-05	2	186	2	38811818
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DMXL2 CUX2 KDM3B TNRC6B TENM4 NRXN2 PCNX1 SNRNP200	3.08e-05	225	186	8	12168954
Pubmed	Developmental origin of the neuronal subtypes that comprise the amygdalar fear circuit in the mouse.	MEF2C SP8 DBX1	3.20e-05	12	186	3	20484636
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	BHLHE41 CUX2 IRX5 LHX6 MEF2C HOXA7 HOXA10 SP8 HOXC11 NFATC3 LHX5 PRRX2	4.05e-05	544	186	12	28473536
Pubmed	Expression patterns of developmental control genes in normal and Engrailed-1 mutant mouse spinal cord reveal early diversity in developing interneurons.	DLL1 DBX1 LHX5	4.14e-05	13	186	3	9315901
Pubmed	Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol.	GRIK4 GRM1 GRM4	4.14e-05	13	186	3	20859245
Pubmed	Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midline.	CUX2 GRIK4 DBX1 LHX5	5.07e-05	38	186	4	18579678
Pubmed	Organization and expression of mouse Hox3 cluster genes.	HOXA7 HOXA10 HOXC11	5.25e-05	14	186	3	8099712
Pubmed	Pbx Regulates Patterning of the Cerebral Cortex in Progenitors and Postmitotic Neurons.	CUX2 LHX6 SP8 DBX1	6.23e-05	40	186	4	26671461
Pubmed	Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.	CUX2 ID4 LHX6 MEF2C SP8 DBX1	7.43e-05	130	186	6	19386638
Pubmed	OTX2 Transcription Factor Controls Regional Patterning within the Medial Ganglionic Eminence and Regional Identity of the Septum.	ID4 LHX6 SP8 DBX1	7.56e-05	42	186	4	26166575
Pubmed	Integrin requirement for hippocampal synaptic plasticity and spatial memory.	ITGA6 ITGA1 ITGB5	8.01e-05	16	186	3	12904471
Pubmed	Delineation of multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes.	LHX6 DBX1 LHX5	8.01e-05	16	186	3	17804629
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SPATA7 SHROOM3 PODXL BMS1 KDM3B TNRC6B BEND3 GPRIN3 SH3BP4 CDCA2 RACK1 SNRNP200 RPL18 XPR1	8.26e-05	777	186	14	35844135
Pubmed	Conditional Knockout of Neurexins Alters the Contribution of Calcium Channel Subtypes to Presynaptic Ca2+ Influx.	NRXN3 NRXN2	8.50e-05	3	186	2	38891114
Pubmed	Orai1 inhibitor STIM2β regulates myogenesis by controlling SOCE dependent transcriptional factors.	MEF2C NFATC3	8.50e-05	3	186	2	31346235
Pubmed	hMusTRD1alpha1 represses MEF2 activation of the troponin I slow enhancer.	GTF2IRD1 MEF2C	8.50e-05	3	186	2	12857748
Pubmed	Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells.	MAP3K5 ROS1	8.50e-05	3	186	2	26707143
Pubmed	Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit.	ITGA6 ITGA1	8.50e-05	3	186	2	18032737
Pubmed	SMURF2 and SMAD7 induce SARA degradation via the proteasome.	ZFYVE9 SMURF2	8.50e-05	3	186	2	32283253
Pubmed	Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development.	ITPKC NFATC3	8.50e-05	3	186	2	14517551
Pubmed	NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.	FLT3 NSD1	8.50e-05	3	186	2	25145343
Pubmed	alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.	NRXN3 NRXN2	8.50e-05	3	186	2	16406382
Pubmed	Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.	NRXN3 NRXN2	8.50e-05	3	186	2	31005376
Pubmed	Integrity of intracellular domain of Notch ligand is indispensable for cleavage required for release of the Notch2 intracellular domain.	DLL1 NOTCH4	8.50e-05	3	186	2	11823422
Pubmed	Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.	FLNB FLNC	8.50e-05	3	186	2	12393796
Pubmed	Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia.	FLT3 JAK2	8.50e-05	3	186	2	19540590
Pubmed	Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway.	JAK2 PRDX5	8.50e-05	3	186	2	23831231
Pubmed	Contribution of Intellectual Disability-Related Genes to ADHD Risk and to Locomotor Activity in Drosophila.	MEF2C TRAPPC9	8.50e-05	3	186	2	32046534
Pubmed	Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.	FLT3 NSD1	8.50e-05	3	186	2	24951466
Pubmed	Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals.	NRXN3 NRXN2	8.50e-05	3	186	2	26446217
Pubmed	Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.	NRXN3 NRXN2	8.50e-05	3	186	2	11944992
Pubmed	Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosis.	NRXN3 NRXN2	8.50e-05	3	186	2	33058888
Pubmed	Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.	NRXN3 NRXN2	8.50e-05	3	186	2	17035546
Pubmed	Neurexins: three genes and 1001 products.	NRXN3 NRXN2	8.50e-05	3	186	2	9448462
Pubmed	Deletion of α-neurexin II results in autism-related behaviors in mice.	NRXN3 NRXN2	8.50e-05	3	186	2	25423136
Pubmed	Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.	FLNB FLNC	8.50e-05	3	186	2	11153914
Pubmed	Model for the exceptional reactivity of peroxiredoxins 2 and 3 with hydrogen peroxide: a kinetic and computational study.	PRDX5 PRRX2	8.50e-05	3	186	2	21385867
Pubmed	OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum.	TRPV1 OS9	8.50e-05	3	186	2	17932042
Pubmed	Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.	NRXN3 NRXN2	8.50e-05	3	186	2	34133920
Pubmed	Filamins as integrators of cell mechanics and signalling.	FLNB FLNC	8.50e-05	3	186	2	11252955
Pubmed	SELENOP modifies sporadic colorectal carcinogenesis and WNT signaling activity through LRP5/6 interactions.	SELENOP LRIG1	8.50e-05	3	186	2	37166989
Pubmed	P120-GAP associated with syndecan-2 to function as an active switch signal for Src upon transformation with oncogenic ras.	RASA1 RACK1	8.50e-05	3	186	2	15752734
Pubmed	[Tyrosine kinase mutation and acute myeloid leukemia with T (8; 21)].	FLT3 JAK2	8.50e-05	3	186	2	19698218
Pubmed	The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice.	NRXN3 NRXN2	8.50e-05	3	186	2	30858964
Pubmed	A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia.	FLT3 JAK2	8.50e-05	3	186	2	19181784
Pubmed	Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2).	GRM4 GRK2	8.50e-05	3	186	2	15102938
Pubmed	Timing of gene expression and oolemma localization of mouse alpha6 and beta1 integrin subunits during oogenesis.	ITGA6 ITGA1	8.50e-05	3	186	2	9698453
Pubmed	Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex.	NRXN3 NRXN2	8.50e-05	3	186	2	28013231
Pubmed	Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion.	NRXN3 NRXN2	8.50e-05	3	186	2	31812984
Pubmed	Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing.	NRXN3 NRXN2	8.50e-05	3	186	2	12036300
Pubmed	β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.	NRXN3 NRXN2	8.50e-05	3	186	2	26213384
Pubmed	Neurexin gene family variants as risk factors for autism spectrum disorder.	NRXN3 NRXN2	8.50e-05	3	186	2	29045040
Pubmed	Novel immunophenotypic and morphologic presentation in acute myeloid leukemia (AML) with JAK2 V617F mutation.	FLT3 JAK2	8.50e-05	3	186	2	19824900
Pubmed	Structural and functional characterization of the IgSF21-neurexin2α complex and its related signaling pathways in the regulation of inhibitory synapse organization.	NRXN3 NRXN2	8.50e-05	3	186	2	38571813
Pubmed	Deletion of β-Neurexins in Mice Alters the Distribution of Dense-Core Vesicles in Presynapses of Hippocampal and Cerebellar Neurons.	NRXN3 NRXN2	8.50e-05	3	186	2	35173587
Pubmed	JAK2 regulates Nav1.6 channel function via FGF14Y158 phosphorylation.	JAK2 FGF14	8.50e-05	3	186	2	32599005
Pubmed	RACK1, a protein kinase C scaffolding protein, interacts with the PH domain of p120GAP.	RASA1 RACK1	8.50e-05	3	186	2	11350068
Pubmed	Neurexins are differentially expressed in the embryonic nervous system of mice.	NRXN3 NRXN2	8.50e-05	3	186	2	7722633
Pubmed	NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia.	FLT3 NSD1	8.50e-05	3	186	2	37147424
Pubmed	Human transcription factor protein interaction networks.	UIMC1 ARHGAP32 BMS1 HIPK2 BAZ1B ID4 TNRC6B BEND3 RBM28 LHX6 MEF2C CDCA2 HOXA10 FBN2 HOXC11 RACK1 NFIA NFATC3 TRAPPC9 CPEB1	8.80e-05	1429	186	20	35140242
Pubmed	Functional proteomics mapping of a human signaling pathway.	UIMC1 FLNB FLNC EGLN2 NAGK KDM3B FBN2 ZFYVE9 MAST4 VPS41 OS9 SMURF2	8.89e-05	591	186	12	15231748
Pubmed	MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders.	GRM4 MEF2C NRXN3	9.68e-05	17	186	3	27779093
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SPATA7 FLNB FLNC MCM2 ITGA1 SLFN5 COQ3 CR1L ITGB5 LUZP1 RACK1 CELSR2 LRIG1 AK2 LTBP1 LOXL3 PRDX5 SNRNP200 TRAPPC9 RPL18	1.08e-04	1451	186	20	30550785
Pubmed	Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.	FLNB FLNC RACK1 PRDX5	1.08e-04	46	186	4	33403043
Pubmed	Identification of NPM-ALK interacting proteins by tandem mass spectrometry.	MAP3K5 MAPK8IP3 JAK2 CASKIN1	1.18e-04	47	186	4	14968112
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	FLNB FLNC NAGK SPOCK1 GPRIN3 SPAG5 RACK1 NFIA CLIC1 AK2 PCNX1 PRDX5 SNRNP200 RPL18	1.23e-04	807	186	14	30575818
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	HIVEP2 ZNF229 ZNF623 ZNF2 ZNF430 SP8 ZNF19 ZNF610 ZNF469 ZBTB39 ZNF425 ZNF431 ZNF528 ZNF417 ZNF614	1.09e-04	718	123	15	28
Coexpression	GSE45365_WT_VS_IFNAR_KO_BCELL_DN	FLNB SELENOP PRSS55 COQ3 CEP43 SPAG5 CDCA2 SP8 WDHD1	9.54e-06	192	185	9	M9987
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MPP2 ATRN FLNB COL6A3 RAB11FIP2 HIPK2 ID4 TNRC6B COQ3 MAP3K5 MAPK8IP3 SH3BP4 CDCA2 JAK2 NOD1 NKD1 LRIG1 SH3D19 LRP4 PCNX1 LTBP1 CORO7	1.15e-05	1102	185	22	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MPP2 ATRN FLNB COL6A3 RAB11FIP2 HIPK2 ID4 TNRC6B COQ3 MAP3K5 MAPK8IP3 SH3BP4 CDCA2 JAK2 NOD1 NKD1 LRIG1 SH3D19 LRP4 PCNX1 LTBP1 CORO7	1.56e-05	1124	185	22	MM1070
Coexpression	GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP	BMS1 LRRC40 BBS9 MECR RACK1 VPS41 SMURF2 RPL18	2.47e-05	166	185	8	M6811
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL6A3 IL16 GRIK4 ITGA1 ADAMTSL3 IGSF10 NKD1 SH3D19 FGF14 LTBP1 BICC1	6.37e-10	195	185	11	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 GRIK4 ITGA1 TENM4 NKD1 KIAA1755 FGF14 LTBP1 BICC1 PRRX2	7.10e-10	197	185	11	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 IL16 GRIK4 ITGA1 ADAMTSL3 NKD1 SH3D19 FGF14 LTBP1 BICC1	8.38e-09	192	185	10	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 SPOCK1 IGSF10 NRXN2 NFIA SH3D19 KIAA1755 LTBP1 BICC1 PRRX2	1.24e-08	200	185	10	8d2ceb2080c67b20f452eeca605aa27a58033c04
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL6A3 SPOCK1 IGSF10 NRXN2 NFIA SH3D19 KIAA1755 LTBP1 BICC1 PRRX2	1.24e-08	200	185	10	c338a08c1605527ab9aaf62ea151a19e8469dc6d
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL6A3 SPOCK1 IGSF10 NRXN2 NFIA SH3D19 KIAA1755 LTBP1 BICC1 PRRX2	1.24e-08	200	185	10	0b2614b8513693dd508c9003699049efd9abac52
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 SPOCK1 ADAMTSL3 GASK1B TENM4 NFIA KIAA1755 LTBP1 BICC1	7.41e-08	182	185	9	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 SPOCK1 ADAMTSL3 GASK1B TENM4 NFIA KIAA1755 LTBP1 BICC1	8.52e-08	185	185	9	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL6A3 IL16 GRIK4 ITGA1 ADAMTSL3 NKD1 SH3D19 FGF14 BICC1	9.34e-08	187	185	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 SPOCK1 ADAMTSL3 GASK1B TENM4 NFIA KIAA1755 LTBP1 BICC1	9.78e-08	188	185	9	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 IL16 GRIK4 ITGA1 ADAMTSL3 NKD1 SH3D19 FGF14 BICC1	1.12e-07	191	185	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 IL16 GRIK4 ADAMTSL3 IGSF10 NKD1 SH3D19 LTBP1 BICC1	1.39e-07	196	185	9	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 IL16 ITGA1 ADAMTSL3 NKD1 SH3D19 FGF14 LTBP1 BICC1	1.39e-07	196	185	9	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	COL6A3 IL16 GRIK4 ADAMTSL3 NKD1 SH3D19 FGF14 LTBP1 BICC1	1.52e-07	198	185	9	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 IL16 ITGA1 ADAMTSL3 NKD1 SH3D19 FGF14 LTBP1 BICC1	1.52e-07	198	185	9	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROBO4 FLNB HIVEP2 ITGA6 MEF2C LUZP1 MAST4 GNA13 SMURF2	1.66e-07	200	185	9	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 GRIK4 ITGA1 ADAMTSL3 NKD1 FGF14 LTBP1 BICC1	1.66e-07	200	185	9	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLNB PODXL ITGA6 MEF2C LUZP1 SPAG5 SH3BP4 MAST4 LTBP1	1.66e-07	200	185	9	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 ITGA1 ITGB5 NKD1 FGF14 LTBP1 BICC1 PRRX2	5.09e-07	167	185	8	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	GRIK4 DLL1 HOXA7 HOXA10 FRY ZFYVE9 MAST4 BICC1	5.83e-07	170	185	8	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM184B FLNC HIVEP2 CSMD3 NRXN3 KCND3 RPL18 SPINK5	6.65e-07	173	185	8	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM184B FLNC HIVEP2 CSMD3 NRXN3 KCND3 RPL18 SPINK5	6.65e-07	173	185	8	649b08a409095592cccf31883be69c754411280d
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-E\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ROBO4 FAM184B PODXL HIPK2 ITGA6 ITGA1 MEF2C NOTCH4	6.95e-07	174	185	8	4a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAM184B SHROOM3 ITGA6 CSMD3 SH3BP4 NRXN3 PLCL1 CRYBG3	9.36e-07	181	185	8	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL ITGA6 ITGA1 MEF2C GASK1B ZNF469 PLCL1 NOTCH4	1.02e-06	183	185	8	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL ITGA6 ITGA1 MEF2C GASK1B ZNF469 PLCL1 NOTCH4	1.02e-06	183	185	8	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 SPOCK1 ITGA1 ADAMTSL3 TENM4 NKD1 LRP4 BICC1	1.02e-06	183	185	8	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 SPOCK1 ADAMTSL3 KCND3 SH3D19 KIAA1755 BICC1 PRRX2	1.10e-06	185	185	8	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP32 SHROOM3 IRX5 NRXN3 TENM4 MAST4 ROS1 MTCL1	1.15e-06	186	185	8	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 FLNB PODXL ITGA6 GRIK4 SLFN5 MEF2C NOTCH4	1.20e-06	187	185	8	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL6A3 IL16 ITGA1 ADAMTSL3 TENM4 FGF14 LTBP1 BICC1	1.20e-06	187	185	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 HIPK2 B3GALT5 TENM4 NKD1 LRP4 FGF14 LTBP1	1.20e-06	187	185	8	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GPRIN3 TMEM247 SLFN5 MAST4 RACK1 LRIG1 PLCL1	1.22e-06	130	185	7	d47d4ff1263815896470d854d25306eb36919e70
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GPRIN3 TMEM247 SLFN5 MAST4 RACK1 LRIG1 PLCL1	1.22e-06	130	185	7	ad57b210c96caedadc1027b4d7a56b1bc389b137
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	ROBO4 PODXL ITGA6 ITGA1 NRXN3 SH3D19 MTCL1 NOTCH4	1.24e-06	188	185	8	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	(6)_ILC\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SHROOM3 ABCB5 B3GALT5 DLL1 SH3BP4 HOXA7 HOXA10 BICC1	1.24e-06	188	185	8	de7cb273899d0e0748c85f45c6b5e7f0642ab057
ToppCell	(6)_ILC\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SHROOM3 ABCB5 B3GALT5 DLL1 SH3BP4 HOXA7 HOXA10 BICC1	1.24e-06	188	185	8	f4734d5b703678670ece204a0519cf015e180a6e
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A3 IL16 ITGA1 ADAMTSL3 NKD1 FGF14 LTBP1 BICC1	1.35e-06	190	185	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ROBO4 PODXL ITGA6 ITGA1 SLFN5 DLL1 NKD1 NOTCH4	1.46e-06	192	185	8	6b69bb8fab9b470850eba1a070a500435ec233cd
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROBO4 FLNB PODXL ITGA6 GRIK4 SLFN5 MEF2C NOTCH4	1.46e-06	192	185	8	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	ABCB5 HIPK2 B3GALT5 DLL1 SH3BP4 HOXA7 FRY BICC1	1.46e-06	192	185	8	e16035b3328f9b1b2e28d234c62ba88387540550
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 SPOCK1 ADAMTSL3 KIAA1755 LTBP1 BICC1 CPEB1 PRRX2	1.46e-06	192	185	8	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 IL16 SPOCK1 ADAMTSL3 MAP3K5 NFIA FGF14 LTBP1	1.51e-06	193	185	8	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	FLNB CUX2 CEP43 SH3BP4 NRXN3 NKD1 NFATC3 SH3D19	1.51e-06	193	185	8	503a979328c68b096680b71359a26f02fafdff35
ToppCell	facs-MAT-Fat-3m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 PODXL ITGA6 ITGA1 DLL1 LHX6 FRY NOTCH4	1.51e-06	193	185	8	e164f6403a8b541ced08a6feec915d2e855036ea
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 GRM1 MEF2C SLC6A7 NRXN3 TENM4 CELSR2 NRXN2	1.51e-06	193	185	8	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 GRM1 MEF2C SLC6A7 NRXN3 TENM4 CELSR2 NRXN2	1.51e-06	193	185	8	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-MAT-Fat-3m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 PODXL ITGA6 ITGA1 DLL1 LHX6 FRY NOTCH4	1.51e-06	193	185	8	b32533afeff1905e188becaa09079e9699722e4b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 IL16 GRIK4 ADAMTSL3 NKD1 SH3D19 LTBP1 BICC1	1.51e-06	193	185	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	facs-MAT-Fat-3m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 PODXL ITGA6 ITGA1 DLL1 LHX6 FRY NOTCH4	1.51e-06	193	185	8	2ff573ba2c74583ed1cb071a3bbc01bb71117e5f
ToppCell	droplet-Lung-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ROBO4 PODXL ITGA6 ITGA1 SLFN5 DLL1 NKD1 NOTCH4	1.51e-06	193	185	8	95c9c63bddfed1a84393ccd3578cfe65bc0c1c05
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 GRM1 MEF2C SLC6A7 NRXN3 TENM4 CELSR2 NRXN2	1.51e-06	193	185	8	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Heart-LA-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 PODXL ITGA6 ITGA1 SLFN5 GASK1B FRY NOTCH4	1.57e-06	194	185	8	33cc4f1d716cb71d54cdedbe9bbdc0d7b17c4777
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MPP2 COL6A3 IL16 ADAMTSL3 NFIA KIAA1755 LTBP1 BICC1	1.64e-06	195	185	8	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 SPOCK1 ITGB5 IGSF10 SH3D19 KIAA1755 LTBP1 BICC1	1.64e-06	195	185	8	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	15-Distal-Endothelial\|Distal / Age, Tissue, Lineage and Cell class	ROBO4 PODXL ITGA6 LHX6 MEF2C GASK1B FRY NOTCH4	1.70e-06	196	185	8	03245aca5cb97fd5c3f8a986efff7131ccd40e34
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ADAMTSL3 IGSF10 NRXN2 NFIA LRP4 LTBP1 BICC1	1.70e-06	196	185	8	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ADAMTSL3 IGSF10 NRXN2 NFIA LRP4 LTBP1 BICC1	1.70e-06	196	185	8	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	15-Distal-Endothelial-Endothelial\|Distal / Age, Tissue, Lineage and Cell class	ROBO4 PODXL ITGA6 LHX6 MEF2C GASK1B FRY NOTCH4	1.70e-06	196	185	8	fda2dd3895bf6ae39fcce2050e4878750f5f5b71
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 SPOCK1 ITGB5 SH3D19 KIAA1755 LTBP1 BICC1 PRRX2	1.77e-06	197	185	8	c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	HIPK2 ITGA6 ITGA1 GTF2IRD1 NRXN3 MAST4 SMURF2 NOTCH4	1.77e-06	197	185	8	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	SHROOM3 ID4 ITGB5 MAP3K5 MAST4 LRIG1 LRP4 LTBP1	1.77e-06	197	185	8	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	SHROOM3 ID4 ITGB5 MAP3K5 MAST4 LRIG1 LRP4 LTBP1	1.77e-06	197	185	8	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 SELENOP GRIK4 CSMD3 IGSF10 MAST4 NFIA SH3D19	1.77e-06	197	185	8	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	10x3'2.3-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 SELENOP PODXL ITGA6 ITGA1 GASK1B MAST4 NOTCH4	1.83e-06	198	185	8	2630a7a6e56febe5c0b0bde70dd7292fa1650c47
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ROBO4 SELENOP PODXL ITGA6 ITGA1 GASK1B MAST4 NOTCH4	1.83e-06	198	185	8	1e83bec16dcd60460422625f89952ff506d6be51
ToppCell	Transverse-(3)_ILC-(30)_ILC\|Transverse / shred on region, Cell_type, and subtype	KCTD9 ABCB5 B3GALT5 DLL1 HOXA7 HOXA10 FRY BICC1	1.98e-06	200	185	8	528520dc98775aca6cc7568fedf5906ea55e0bea
ToppCell	Transverse-(3)_ILC\|Transverse / shred on region, Cell_type, and subtype	KCTD9 ABCB5 B3GALT5 DLL1 HOXA7 HOXA10 FRY BICC1	1.98e-06	200	185	8	c1ad7cb012e1c8911e417f7d64ca662c4f5010e0
ToppCell	Transverse-ILC\|Transverse / Region, Cell class and subclass	KCTD9 ABCB5 B3GALT5 DLL1 HOXA7 HOXA10 FRY BICC1	1.98e-06	200	185	8	eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe
ToppCell	mild-NK_CD56bright\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLNB SLFN5 DLL1 MEX3C SH3BP4 HOXA7 HOXA10 PRF1	1.98e-06	200	185	8	a195bc6784346f706d4cd5b740adac1d950ce88a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 GRIK4 ITGA1 ADAMTSL3 NKD1 FGF14 BICC1	1.98e-06	200	185	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 GRIK4 ADAMTSL3 NKD1 SH3D19 FGF14 BICC1	1.98e-06	200	185	8	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Transverse-ILC-ILC\|Transverse / Region, Cell class and subclass	KCTD9 ABCB5 B3GALT5 DLL1 HOXA7 HOXA10 FRY BICC1	1.98e-06	200	185	8	60ec185df2f1989bf8febf75b11c46a576829be3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 GRIK4 ADAMTSL3 NKD1 FGF14 LTBP1 BICC1	1.98e-06	200	185	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 GRIK4 ADAMTSL3 NKD1 FGF14 LTBP1 BICC1	1.98e-06	200	185	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 IL16 SPOCK1 ADAMTSL3 KIAA1755 LTBP1 BICC1 PRRX2	1.98e-06	200	185	8	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	normal_Lung-Fibroblasts-COL14A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	COL6A3 SELENOP SPOCK1 ADAMTSL3 IGSF10 NFIA LTBP1 BICC1	1.98e-06	200	185	8	ee3d06865a6300e1279edf6664320b71647f5efb
ToppCell	10x5'-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	SELENOP PRSS16 CR1L ZNF2 DNAAF8 FBN2 SMURF2	2.11e-06	141	185	7	7671d300b1722711fd2d8034b96a3aa7e3ccb560
ToppCell	Dendritic_Cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	FLNB IL16 MEF2C JAK2 HOXA10 ZNF469 TENM4	3.32e-06	151	185	7	e089bf197ed60e7243160521d4390d4b40a3832b
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNB PTPN22 DLL1 GASK1B FAM20C MAST4 WDHD1	5.96e-06	165	185	7	62457b7b74c6eae42d91d65e7dc6df6bf8e061f7
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MPP2 DLL1 LHX6 SH3BP4 THOC6 VPS41 CRYBG3	6.71e-06	168	185	7	32e4d82efaccf336d347e4063253c3635a3ec672
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRACR2A PTPN22 ITGA1 SLFN5 PRF1 PCNX1 PLCL1	6.97e-06	169	185	7	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SHROOM3 ABCB5 B3GALT5 SH3BP4 HOXA7 HOXA10 BICC1	7.25e-06	170	185	7	6c65ddb496030bb479ef346cc37a9d4dfa6b824f
ToppCell	normal-na-Lymphocytic_NK-natural_killer_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	USP43 GRIK4 HOXA10 CELSR2 PRF1 LTBP1 CPEB1	7.53e-06	171	185	7	d339840626211a7bf1a9eb8f14d6c9509ab05e1c
ToppCell	356C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ITGA1 HOXA10 NOD1 SH3D19 ZNF417 TRAPPC9 FHIP2B	7.53e-06	171	185	7	3d26ef58fe5231373d7df9ac79d225546918cf82
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IRX5 ID4 CELSR2 LRP4 FGF14 ZNF614 BICC1	7.53e-06	171	185	7	effcc4b6d26eafc2ca6fa08b6fee2689eff48f0f
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 PODXL MEF2C GASK1B NOD1 LTBP1 NOTCH4	9.78e-06	178	185	7	6bef4ef48f649c6e38ae732bc08e6d7814db588b
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	SHROOM3 B3GALT5 MAST4 LRIG1 NFIA PROM2 PLCL1	9.78e-06	178	185	7	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROBO4 IL16 PODXL ITGA6 SLFN5 LHX6 SPAG5	9.78e-06	178	185	7	60263c0bb9de3a57ba2ba543262a2ace0066fd85
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAM184B SHROOM3 ITGA6 SH3BP4 NRXN3 PLCL1 CRYBG3	1.01e-05	179	185	7	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	COL6A3 SPOCK1 NFIA SH3D19 KIAA1755 FGF14 BICC1	1.01e-05	179	185	7	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ITGA1 ZNF229 ZNF2 LRP4 KIAA1755 LTBP1	1.09e-05	181	185	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ID4 HOXA10 NKD1 LRIG1 KCND3 LTBP1 MTCL1	1.13e-05	182	185	7	37547b36264090b49a193a8ef3a8d88e647f0b79
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 PODXL ID4 IGSF10 NKD1 NRXN2 NOTCH4	1.13e-05	182	185	7	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	FAM184B SHROOM3 ITGA6 SH3BP4 NRXN3 PLCL1 CRYBG3	1.17e-05	183	185	7	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	droplet-Liver-Npc-21m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BHLHE41 FLNC IRX5 FBN2 CELSR2 PROM2 DUOXA2	1.17e-05	183	185	7	99ab7a43527eb226027efbcd8c0b6a8e46fc3c93
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA6 ITGA1 MEF2C GASK1B CELSR2 KIAA1755 LOXL3	1.17e-05	183	185	7	547b1fb9f9940cfc8d6e351d96acc0da44def57e
ToppCell	droplet-Liver-Npc-21m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BHLHE41 FLNC IRX5 FBN2 CELSR2 PROM2 DUOXA2	1.17e-05	183	185	7	28916f0597690ff534578be2cb715b485cb1de1a
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	FLNB HIPK2 ID4 ITGA1 FRY NKD1 RNF180	1.17e-05	183	185	7	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	KCTD9 ABCB5 B3GALT5 DLL1 HOXA7 HOXA10 BICC1	1.21e-05	184	185	7	479e60f76c191253e23699c9dd7ef7efc08c59ad
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	ARHGAP32 HIVEP2 NSD1 ITGA6 TNRC6B JAK2 HOXA10 GRK2 MAST4 PCNX1 MTCL1 CPEB1	2.43e-08	177	185	12	4652_DN
Drug	valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A	ROBO4 ID4 PTPN22 CNTLN GRM4 MAPK8IP3 FRY KCND3 PCNX1 ZNF528 CPEB1	7.02e-07	198	185	11	6378_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ROBO4 TRPV1 HIVEP2 HIPK2 CNTLN ITGB5 GSK3A EXD3 ZFYVE9 NFATC3 PCNX1	7.38e-07	199	185	11	1470_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	DMXL2 HIVEP2 LHX6 BBS9 GSK3A LUZP1 MAPK8IP3 MAST4 LRIG1 PCNX1	1.51e-06	172	185	10	1017_UP
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ZCWPW1 HIPK2 LHX6 MAPK8IP3 ZBTB39 MAST4 CUZD1 AK2 PCNX1 FHIP2B	4.66e-06	195	185	10	3508_DN
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A	PRSS16 GRM1 ZNF623 BBS9 MAPK8IP3 HOXA7 NOD1 NRXN3 MAST4 VPS41	4.87e-06	196	185	10	4548_DN
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A	BAZ1B BBS9 GSK3A JAK2 NOD1 HOXC11 MAST4 PCNX1 ZNF528 FHIP2B	4.87e-06	196	185	10	3760_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	BHLHE41 LRP12 DMXL2 PODXL BAZ1B TNRC6B GSK3A ZFYVE9 NFATC3 PCNX1	4.87e-06	196	185	10	3383_DN
Drug	Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MPP2 LRP12 BAZ1B TNRC6B BBS9 MAPK8IP3 JAK2 ZFYVE9 WDHD1 RPL18	5.10e-06	197	185	10	6099_DN
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MPP2 HIPK2 BAZ1B LHX6 BBS9 GSK3A ZFYVE9 AK2 PCNX1 SPINK5	5.33e-06	198	185	10	5492_DN
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	KLC2 ITGA6 BAZ1B GRM1 ITGB5 LUZP1 NFATC3 GNA13 TRAPPC9 SPINK5	5.33e-06	198	185	10	6489_DN
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A	ATRN ARHGAP32 MYT1 HIPK2 GRM1 EXD3 GRK2 CELSR2 PLCL1 RPL18	5.83e-06	200	185	10	2905_DN
Drug	acromelic acid A	LDHAL6B GRIK4 GRM1 GRM4	1.18e-05	18	185	4	CID000108086
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	IPPK MPP2 ZCWPW1 BAZ1B GSK3A LUZP1 AK2 PCNX1 RPL18	2.75e-05	191	185	9	2789_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	BHLHE41 LRP12 PRSS16 BAZ1B PTPN22 GSK3A LUZP1 MAPK8IP3 SPINK5	2.87e-05	192	185	9	4395_DN
Drug	Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A	IL16 GRIK4 NRXN3 MAST4 NRXN2 NFATC3 KCND3 LRP4 ZNF528	2.87e-05	192	185	9	5101_UP
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	EGLN2 LRP12 LHX6 BBS9 GSK3A JAK2 MAST4 MTCL1 ZNF614	2.99e-05	193	185	9	3378_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	RAB11FIP2 HIPK2 NOD1 MAST4 NFATC3 PRF1 AK2 PCNX1 RPL18	3.11e-05	194	185	9	6021_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	LRP12 DMXL2 HIPK2 GASK1B HOXA10 GRK2 PRF1 LRP4 SNRNP200	3.24e-05	195	185	9	3346_UP
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	TRPV1 HIPK2 KLC2 LHX6 MAPK8IP3 JAK2 EXD3 MAST4 MTCL1	3.24e-05	195	185	9	5447_DN
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	FLT3 GRM1 MAPK8IP3 HOXA10 FRY LRP4 ZNF528 TRAPPC9 CPEB1	3.51e-05	197	185	9	3924_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	HIPK2 BAZ1B MAPK8IP3 HOXA7 HOXC11 ZFYVE9 MAST4 CUZD1 AK2	3.51e-05	197	185	9	4318_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TRPV1 BAZ1B BBS9 ITPKC HOXC11 GRK2 MAST4 NFATC3 HMGXB3	3.51e-05	197	185	9	7186_DN
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	TRPV1 RAB11FIP2 HIPK2 BAZ1B TNRC6B MAPK8IP3 EXD3 AK2 SPINK5	3.51e-05	197	185	9	4699_DN
Drug	cysteine sulfinic acid	GRM1 GRM4 PLEKHM1 PRDX5 PRRX2	3.51e-05	46	185	5	CID000000109
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A	ATRN FLNB HIPK2 BAZ1B TNRC6B HOXA10 ITPKC FBN2 ZNF614	3.65e-05	198	185	9	3081_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	LRP12 HIPK2 GRM1 MAPK8IP3 ZFYVE9 GRK2 KCND3 TRAPPC9 SPINK5	3.65e-05	198	185	9	6778_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	LRP12 HIVEP2 BAZ1B BBS9 MAPK8IP3 EXD3 MAST4 AK2 RPL18	3.65e-05	198	185	9	3869_DN
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	BHLHE41 COL6A3 TRPV1 BAZ1B PTPN22 GSK3A MAPK8IP3 TENM4 RPL18	3.65e-05	198	185	9	3879_UP
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	GRM1 LUZP1 MAPK8IP3 NOD1 ZFYVE9 MAST4 AK2 PCNX1 RPL18	3.65e-05	198	185	9	6080_DN
Drug	Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	TRPV1 BAZ1B PTPN22 GSK3A MAPK8IP3 HOXC11 ZFYVE9 PCNX1 SPINK5	3.65e-05	198	185	9	6270_UP
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A	BHLHE41 LUZP1 MAPK8IP3 ZFYVE9 GRK2 LRIG1 NFATC3 CUZD1 AGBL2	3.80e-05	199	185	9	2625_UP
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A	MPP2 LRP12 KLC2 BAZ1B TNRC6B MAPK8IP3 EXD3 ZBTB39 HMGXB3	3.80e-05	199	185	9	3249_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	MPP2 NSD1 HIPK2 KLC2 BAZ1B CEP43 ITPKC GRK2 FHIP2B	3.80e-05	199	185	9	1813_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MPP2 GRM1 ZNF623 BBS9 MAPK8IP3 ZBTB39 ZFYVE9 PCNX1 SPINK5	3.80e-05	199	185	9	2310_DN
Drug	Tyloxapol [25301-02-4]; Down 200; 4uM; HL60; HT_HG-U133A	IPPK FLNB DMXL2 TRPV1 IRX5 RAB11FIP2 BAZ1B ITPKC NFATC3	3.80e-05	199	185	9	3074_DN
Drug	Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	ZCWPW1 CNTLN BBS9 GSK3A TENM4 PCNX1 ZNF528 ZNF614 BICC1	3.95e-05	200	185	9	4088_DN
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; PC3; HT_HG-U133A	LRP12 HIVEP2 BAZ1B TNRC6B MAPK8IP3 JAK2 MECR PCNX1 ZNF528	3.95e-05	200	185	9	6333_DN
Drug	11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene	FLT3 JAK2	6.57e-05	2	185	2	ctd:C561234
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	COL6A3 ARHGAP32 PODXL MAP3K5 JAK2 HOXA10 NOD1 CPEB1	1.25e-04	182	185	8	3808_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; HL60; HG-U133A	MPP2 EGLN2 KDM3B PTPN22 HOXA10 ZFYVE9 GNA13 TRAPPC9	1.63e-04	189	185	8	1742_UP
Drug	Digoxigenin [1672-46-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	BHLHE41 SPATA7 MCMBP ZCWPW1 GRM1 LHX6 CEP43 GSK3A	1.69e-04	190	185	8	4680_DN
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	SPATA7 TRPV1 MCMBP HOXA10 TENM4 ZFYVE9 VPS41 PCNX1	1.69e-04	190	185	8	4493_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	BHLHE41 HIVEP2 BAZ1B ID4 LHX6 BBS9 PCNX1 ZNF614	1.75e-04	191	185	8	6024_DN
Drug	Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A	LRP12 PRSS16 ITGA6 LHX6 JAK2 CELSR2 LRIG1 CUZD1	1.75e-04	191	185	8	7342_UP
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; MCF7; HT_HG-U133A	LRP12 DMXL2 BAZ1B LHX6 NFATC3 AK2 PCNX1 SPINK5	1.75e-04	191	185	8	3386_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A	HIVEP2 RAB11FIP2 ITGA6 LRRC40 MEF2C MEX3C WDHD1 OS9	1.81e-04	192	185	8	1929_DN
Drug	PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A	HIPK2 GRM1 GRM4 MEF2C GSK3A HOXA10 GRK2 PCNX1	1.81e-04	192	185	8	5967_UP
Drug	carmustine; Down 200; 100uM; PC3; HT_HG-U133A	MPP2 SPATA7 TRPV1 LHX6 MEF2C LUZP1 ZBTB39 FBN2	1.94e-04	194	185	8	6883_DN
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	LRP12 DMXL2 BAZ1B GSK3A JAK2 ZNF430 NFATC3 AK2	1.94e-04	194	185	8	3366_DN
Drug	Cesead Opaque Primer	ROBO4 ARHGAP32	1.96e-04	3	185	2	CID000135071
Drug	AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A	ATRN TRPV1 COQ3 LUZP1 JAK2 ITPKC ZFYVE9 CELSR2	2.01e-04	195	185	8	6903_UP
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	ATRN KLC2 ITGA6 BAZ1B PTPN22 MAST4 CUZD1 PCNX1	2.01e-04	195	185	8	3571_DN
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A	LRP12 DMXL2 HIPK2 LHX6 LUZP1 GRK2 NFATC3 CUZD1	2.01e-04	195	185	8	4393_DN
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A	LRP12 HIPK2 BAZ1B ZNF623 ITGB5 ITPKC MAST4 VPS41	2.01e-04	195	185	8	5053_DN
Drug	DL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA	PODXL BAZ1B ZNF430 ITPKC HOXC11 WDHD1 HMGXB3 LTBP1	2.01e-04	195	185	8	1121_DN
Drug	Leflunomide [75706-12-6]; Up 200; 14.8uM; PC3; HT_HG-U133A	PTPN22 GRM1 GASK1B MAP3K5 ZFYVE9 CELSR2 PCNX1 CPEB1	2.01e-04	195	185	8	5884_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	LRP12 HIVEP2 GRM1 LHX6 BBS9 LUZP1 AGBL2 SPINK5	2.01e-04	195	185	8	2313_DN
Drug	Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MPP2 SPATA7 RAB11FIP2 ZBTB39 MECR WDHD1 PCNX1 TRAPPC9	2.01e-04	195	185	8	6770_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A	MCMBP ID4 PTPN22 BBS9 MAPK8IP3 NOD1 HOXC11 ZNF528	2.01e-04	195	185	8	6761_UP
Drug	Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A	MPP2 LUZP1 MAPK8IP3 JAK2 ZBTB39 ZFYVE9 AK2 PCNX1	2.01e-04	195	185	8	7460_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A	BHLHE41 PTPN22 GRM1 CUZD1 AK2 PCNX1 TRAPPC9 SPINK5	2.08e-04	196	185	8	4416_DN
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MPP2 TNRC6B GRM1 LHX6 ZFYVE9 PRF1 RPL18 SPINK5	2.08e-04	196	185	8	5016_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	ATRN HIVEP2 MAPK8IP3 MAST4 CELSR2 ZNF614 TRAPPC9 CPEB1	2.08e-04	196	185	8	2121_DN
Drug	3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; HL60; HT_HG-U133A	FLNB BBS9 MEF2C ZFYVE9 CELSR2 NFATC3 PLCL1 SNRNP200	2.08e-04	196	185	8	2941_DN
Drug	Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MPP2 ZCWPW1 KLC2 LHX6 MAST4 WDHD1 PCNX1 SPINK5	2.08e-04	196	185	8	3350_DN
Drug	Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	LRP12 SPOCK1 PRSS16 BAZ1B BBS9 MAPK8IP3 GRK2 AK2	2.08e-04	196	185	8	7225_UP
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	ID4 LHX6 BBS9 MAPK8IP3 EXD3 ZFYVE9 GRK2 RPL18	2.08e-04	196	185	8	3842_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; PC3; HT_HG-U133A	ID4 GRM1 MAP3K5 NOD1 CUZD1 LRP4 PCNX1 ZNF528	2.08e-04	196	185	8	4083_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	TRPV1 PTPN22 MAPK8IP3 HOXA10 EXD3 NOD1 MAST4 NFATC3	2.08e-04	196	185	8	5627_UP
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A	MPP2 TRPV1 HIVEP2 BAZ1B EXD3 NFATC3 AK2 TRAPPC9	2.16e-04	197	185	8	3549_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; PC3; HT_HG-U133A	MYT1 ID4 ITGA1 MAP3K5 JAK2 TENM4 LRP4 BICC1	2.16e-04	197	185	8	4091_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A	LRP12 ITGA1 GRM1 ZBTB39 FBN2 PRF1 PCNX1 RPL18	2.16e-04	197	185	8	5840_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	BBS9 GSK3A NRXN3 ZFYVE9 GRK2 CUZD1 ZNF528 RPL18	2.16e-04	197	185	8	3784_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MPP2 ATRN ZNF623 MAPK8IP3 NFATC3 AK2 PCNX1 LTBP1	2.16e-04	197	185	8	5503_DN
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	GRM1 GRM4 BBS9 GSK3A EXD3 NOD1 LRP4 BICC1	2.16e-04	197	185	8	4096_DN
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; MCF7; HT_HG-U133A	BHLHE41 LHX6 BBS9 LUZP1 MAPK8IP3 PRF1 PCNX1 SPINK5	2.16e-04	197	185	8	4709_DN
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A	MPP2 LRP12 GRM1 BBS9 MEF2C MAST4 NFATC3 RPL18	2.16e-04	197	185	8	6798_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A	HIPK2 ID4 LHX6 BBS9 GASK1B GSK3A MAST4 CUZD1	2.16e-04	197	185	8	7009_UP
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MPP2 LRP12 HIPK2 ZFYVE9 NFATC3 AK2 PCNX1 SPINK5	2.16e-04	197	185	8	5493_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	LRP12 TRPV1 MCMBP HIVEP2 BBS9 HOXC11 CELSR2 AK2	2.23e-04	198	185	8	3754_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	DMXL2 TRPV1 BAZ1B ZNF623 MAPK8IP3 CELSR2 AK2 FHIP2B	2.23e-04	198	185	8	6341_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	HIPK2 ID4 ITGA1 BBS9 GSK3A NOD1 VPS41 PCNX1	2.23e-04	198	185	8	4090_DN
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A	MPP2 ZCWPW1 JAK2 FBN2 NFATC3 KCND3 PCNX1 SPINK5	2.23e-04	198	185	8	6275_UP
Drug	Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	LRP12 HIPK2 GRM1 MEF2C GASK1B GRK2 KCND3 LRP4	2.23e-04	198	185	8	3326_UP
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	LRP12 HIVEP2 LUZP1 MAPK8IP3 JAK2 EXD3 MAST4 LRIG1	2.23e-04	198	185	8	3482_UP
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A	ID4 CEP43 EXD3 HOXC11 MAST4 PRF1 PCNX1 ZNF614	2.23e-04	198	185	8	3687_DN
Drug	Iocetamic acid [16034-77-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A	MPP2 HIVEP2 NOD1 HOXC11 CUZD1 HMGXB3 RPL18 SPINK5	2.23e-04	198	185	8	3361_DN
Drug	Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TRPV1 PRSS16 GSK3A WDHD1 GNA13 AK2 PCNX1 RPL18	2.23e-04	198	185	8	5490_DN
Drug	SC 19220; Up 200; 10uM; PC3; HT_HG-U133A	EGLN2 KLC2 TNRC6B CEP43 LUZP1 HOXA10 ITPKC FHIP2B	2.23e-04	198	185	8	7095_UP
Drug	4-META	ARHGAP32 SPOCK1 SPAG5	2.23e-04	15	185	3	CID000051027
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A	GRM1 BBS9 HOXA7 EXD3 MAST4 BICC1 CPEB1 SPINK5	2.31e-04	199	185	8	2120_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	ARHGAP32 TRPV1 NSD1 GSK3A MAPK8IP3 ZFYVE9 CELSR2 PRF1	2.31e-04	199	185	8	2683_DN
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	CUX2 GSK3A MAPK8IP3 NRXN3 TENM4 AK2 PCNX1 TRAPPC9	2.31e-04	199	185	8	3615_UP
Drug	Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	FLNB DMXL2 GRM4 JAK2 EXD3 ZBTB39 GRK2 CUZD1	2.31e-04	199	185	8	6489_UP
Drug	Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MPP2 BAZ1B LHX6 ZFYVE9 GNA13 HMGXB3 FHIP2B SPINK5	2.31e-04	199	185	8	2760_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	MPP2 PODXL LUZP1 JAK2 TENM4 CELSR2 LRIG1 TRAPPC9	2.31e-04	199	185	8	1021_UP
Drug	Debrisoquin sulfate [581-88-4]; Down 200; 9uM; PC3; HT_HG-U133A	KLC2 BAZ1B GRM1 CEP43 GSK3A PRF1 PCNX1 SPINK5	2.39e-04	200	185	8	6688_DN
Drug	Denatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A	ITGA6 MEF2C NOD1 FBN2 KCND3 CUZD1 AK2 RPL18	2.39e-04	200	185	8	6502_UP
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; PC3; HT_HG-U133A	IPPK SPATA7 BAZ1B ITGA1 MAP3K5 MAPK8IP3 PCNX1 CPEB1	2.39e-04	200	185	8	4475_DN
Disease	cortical thickness	GDF5-AS1 FLNB SHROOM3 ABCA4 TNRC6B BEND3 ADAMTSL3 BBS9 AP3M1 ITGB5 MEF2C PLEKHM1 LUZP1 MAPK8IP3 SP8 ZNF469 FBN2 MAST4 NFIA GNA13 LRP4 KIAA1755 MTCL1 AGBL2 CPEB1	2.03e-08	1113	180	25	EFO_0004840
Disease	pulse pressure measurement	GDF5-AS1 FLNB COL6A3 SHROOM3 CUX2 PODXL MYT1 TNRC6B ITGA1 GRM4 CR1L ADAMTSL3 ITGB5 LUZP1 RNF215 HOXA7 FBN2 TENM4 LRIG1 KIAA1755 LTBP1 AGBL2 CORO7 TRAPPC9 BICC1 XPR1	3.84e-07	1392	180	26	EFO_0005763
Disease	cortical surface area measurement	SPATA7 FLNB SHROOM3 PODXL MYT1 PRSS55 HIPK2 TNRC6B BEND3 CNTLN ADAMTSL3 BBS9 ITGB5 MEF2C PLEKHM1 LUZP1 SP8 ZNF469 FBN2 MAST4 LRIG1 NFIA KIAA1755 PLCL1 MTCL1	7.21e-07	1345	180	25	EFO_0010736
Disease	neuroimaging measurement	GDF5-AS1 MPP2 SPATA7 SHROOM3 PODXL TNRC6B BEND3 BBS9 ITGB5 LUZP1 MAPK8IP3 SP8 ZNF469 FBN2 MAST4 NFIA GNA13 KIAA1755 PLCL1	3.17e-05	1069	180	19	EFO_0004346
Disease	coronary artery disease	ANKRD31 COL6A3 SHROOM3 CUX2 HIVEP2 USP43 LRRC40 GRIK4 ITGA1 ITGB5 MAPK8IP3 IGSF10 SP8 FBN2 MAST4 CELSR2 NFIA PLCL1 CORO7 BICC1	4.46e-05	1194	180	20	EFO_0001645
Disease	sexual dimorphism measurement	GDF5-AS1 MPP2 ANKRD31 FAM184B SELENOP HIVEP2 PRSS16 PODXL NSD1 BAZ1B ID4 GTF2IRD1 GRM4 ADAMTSL3 NRXN3 ANAPC10 CASKIN1 CDK5RAP1 LTBP1	5.00e-05	1106	180	19	EFO_0021796
Disease	Intellectual Disability	CUX2 HIVEP2 NSD1 KDM3B RBM28 DLL1 MEF2C MAPK8IP3 FRY NRXN2 NFIA	1.02e-04	447	180	11	C3714756
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	1.11e-04	3	180	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	1.11e-04	3	180	2	DOID:0111190 (implicated_via_orthology)
Disease	vital capacity	FAM184B COL6A3 SELENOP SHROOM3 HIVEP2 PRSS16 PODXL MYT1 ID4 GPRIN3 ADAMTSL3 PLEKHM1 HOXA10 ANAPC10 NFIA LTBP1 PLCL1 MTCL1 SMURF2	2.11e-04	1236	180	19	EFO_0004312
Disease	Autistic Disorder	ROBO4 NSD1 DLL1 CSMD3 MEF2C NRXN3 NRXN2 PRF1	2.12e-04	261	180	8	C0004352
Disease	ascending aortic diameter	FLNB COL6A3 TNRC6B FBN2 LRIG1 TRAPPC9	2.26e-04	140	180	6	EFO_0021787
Disease	intraocular pressure measurement	COL6A3 LRP12 ABCA4 GRIK4 BBS9 MAPK8IP3 ZNF469 FBN2 LRP4 LTBP1 BICC1	3.12e-04	509	180	11	EFO_0004695
Disease	Epilepsy, Benign Psychomotor, Childhood	TRPV1 GRM1 GRM4	3.61e-04	23	180	3	C0393672
Disease	Epilepsy, Lateral Temporal	TRPV1 GRM1 GRM4	3.61e-04	23	180	3	C0393682
Disease	Uncinate Epilepsy	TRPV1 GRM1 GRM4	3.61e-04	23	180	3	C0014558
Disease	Epilepsy, Temporal Lobe	TRPV1 GRM1 GRM4	3.61e-04	23	180	3	C0014556
Disease	response to bronchodilator, response to corticosteroid	CSMD3 ZNF614	3.66e-04	5	180	2	GO_0031960, GO_0097366
Disease	Retinal Dystrophy, Early Onset Severe	SPATA7 ABCA4	3.66e-04	5	180	2	C1858080
Disease	Bell's palsy	MYT1 LUZP1 TENM4 DBX1 LOXL3	4.13e-04	102	180	5	EFO_0007167
Disease	electrocardiography	ITGA6 LUZP1 SP8 MAST4 LRIG1 NFIA KCND3 KIAA1755 PCNX1 ROS1 PLCL1	4.38e-04	530	180	11	EFO_0004327
Disease	Early Pregnancy Loss	COL6A3 IL16 CD163 SPAG5 JAK2	5.59e-04	109	180	5	C3830362
Disease	Spontaneous abortion	COL6A3 IL16 CD163 SPAG5 JAK2	5.59e-04	109	180	5	C0000786
Disease	Miscarriage	COL6A3 IL16 CD163 SPAG5 JAK2	5.59e-04	109	180	5	C4552766
Disease	Abortion, Tubal	COL6A3 IL16 CD163 SPAG5 JAK2	5.59e-04	109	180	5	C0000822
Disease	myocardial infarction (implicated_via_orthology)	TRPV1 MEF2C MAP3K5 JAK2	7.19e-04	66	180	4	DOID:5844 (implicated_via_orthology)
Disease	Bipolar Disorder	BHLHE41 CUX2 GRIK4 GRM4 GSK3A SP8 TENM4 RACK1 LHX5 NOTCH4	7.37e-04	477	180	10	C0005586
Disease	Crohn's disease (is_implicated_in)	PTPN22 JAK2 PRF1	8.03e-04	30	180	3	DOID:8778 (is_implicated_in)
Disease	Williams Syndrome	BAZ1B GTF2IRD1	1.01e-03	8	180	2	C0175702
Disease	LDL cholesterol change measurement, response to simvastatin, response to fenofibrate	FGF14 BICC1	1.01e-03	8	180	2	EFO_0007804, GO_1901557, GO_1903491
Disease	Agents acting on the renin-angiotensin system use measurement	PODXL MYT1 HIPK2 MEX3C FBN2 CELSR2 PCNX1 BICC1	1.10e-03	335	180	8	EFO_0009931
Disease	pack-years measurement, systolic blood pressure	FRY NRXN3 TRAPPC9	1.16e-03	34	180	3	EFO_0006335, EFO_0006526
Disease	forced expiratory volume	ZCWPW1 PRSS16 PODXL ID4 ITGA1 CNTLN ADAMTSL3 BBS9 PLEKHM1 NRXN3 ANAPC10 PLCL1 MTCL1	1.17e-03	789	180	13	EFO_0004314
Disease	alopecia areata (is_implicated_in)	PTPN22 NOTCH4	1.30e-03	9	180	2	DOID:986 (is_implicated_in)
Disease	Erythrocytosis familial, 1	EGLN2 JAK2	1.30e-03	9	180	2	C4551637
Disease	leptin measurement	RBM28 NRXN3 GNA13 BICC1	1.55e-03	81	180	4	EFO_0005000
Disease	response to carboplatin, response to antineoplastic agent	FLNB LRIG1	1.61e-03	10	180	2	GO_0097327, GO_0097328
Disease	chronic fatigue syndrome (is_marker_for)	IL16 PRF1	1.61e-03	10	180	2	DOID:8544 (is_marker_for)
Disease	response to bisphosphonate, osteonecrosis	GTF2IRD1 GRM4	1.61e-03	10	180	2	EFO_0004259, EFO_0009958
Disease	liver cirrhosis (is_marker_for)	CD163 JAK2 GRK2 CPEB1	1.62e-03	82	180	4	DOID:5082 (is_marker_for)
Disease	free cholesterol in medium LDL measurement	ANKRD31 ITGA1 CELSR2	1.87e-03	40	180	3	EFO_0022268
Disease	Internal Carotid Artery Diseases	PODXL CD163	1.96e-03	11	180	2	C0750986
Disease	Arterial Diseases, Common Carotid	PODXL CD163	1.96e-03	11	180	2	C0750987
Disease	Carotid Atherosclerosis	PODXL CD163	1.96e-03	11	180	2	C0577631
Disease	External Carotid Artery Diseases	PODXL CD163	1.96e-03	11	180	2	C0600178
Disease	Carotid Artery Diseases	PODXL CD163	1.96e-03	11	180	2	C0007273
Disease	response to virus	CRACR2A BBS9	1.96e-03	11	180	2	GO_0009615
Disease	pro‐interleukin‐16 measurement	IL16 ADAMTSL3	1.96e-03	11	180	2	EFO_0010629
Disease	diet measurement	MPP2 FAM184B FLT3 PRSS16 RAB11FIP2 KDM3B BAZ1B TNRC6B MEF2C PLEKHM1 SP8 ZNF469 NRXN3 TENM4 CELSR2	2.02e-03	1049	180	15	EFO_0008111
Disease	cardiovascular disease	MPP2 HIVEP2 HIPK2 MEX3C SCAF1 FBN2 CELSR2 PCNX1 BICC1	2.06e-03	457	180	9	EFO_0000319
Disease	cholelithiasis	SHROOM3 NSD1 TNRC6B SH3BP4	2.10e-03	88	180	4	EFO_0004799
Disease	brain measurement, neuroimaging measurement	GDF5-AS1 MPP2 BEND3 BBS9 LUZP1 FBN2 MAST4 GNA13 KIAA1755 FGF14	2.12e-03	550	180	10	EFO_0004346, EFO_0004464
Disease	response to methotrexate, serum alanine aminotransferase measurement	ITGA6 MTCL1 TRAPPC9	2.30e-03	43	180	3	EFO_0004735, GO_0031427
Disease	asthma	COL6A3 DMXL2 HIVEP2 MYT1 B3GALT5 GRM4 ADAMTSL3 CSMD3 ZBTB39 SH3D19 PLCL1 NOTCH4	2.31e-03	751	180	12	MONDO_0004979
Disease	osteoarthritis	MPP2 CSMD3 ZNF623 GRK2 KIAA1755 LTBP1	2.49e-03	222	180	6	MONDO_0005178
Disease	hematologic cancer (implicated_via_orthology)	CUX2 JAK2	2.76e-03	13	180	2	DOID:2531 (implicated_via_orthology)
Disease	systolic blood pressure, cigarettes per day measurement	FRY NRXN3	2.76e-03	13	180	2	EFO_0006335, EFO_0006525
Disease	Schizophrenia	ARHGAP32 PRSS16 GRIK4 GRM1 GRM4 ADAMTSL3 LHX6 GSK3A CD163 NRXN3 TENM4 NRXN2 NOTCH4	3.11e-03	883	180	13	C0036341
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	FLNC BICC1	3.21e-03	14	180	2	DOID:898 (implicated_via_orthology)
Disease	parental longevity	SHROOM3 CUX2 SPOCK1 PODXL BEND3 MCM2 MEF2C CELSR2 NFIA	3.46e-03	494	180	9	EFO_0007796
Disease	free cholesterol in LDL measurement	ANKRD31 ITGA1 CELSR2	3.54e-03	50	180	3	EFO_0022266
Disease	Tourette syndrome	FLT3 CSMD3 TENM4	3.54e-03	50	180	3	EFO_0004895
Disease	aspartate aminotransferase to alanine aminotransferase ratio	ANKRD31 BAZ1B PTPN22 COQ3 MROH1 HMGXB3	3.58e-03	239	180	6	EFO_0010934
Disease	Williams-Beuren syndrome (implicated_via_orthology)	BAZ1B GTF2IRD1	3.69e-03	15	180	2	DOID:1928 (implicated_via_orthology)
Disease	free cholesterol in large LDL measurement	ANKRD31 ITGA1 CELSR2	3.75e-03	51	180	3	EFO_0022176
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	ANKRD31 BAZ1B CELSR2	3.75e-03	51	180	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	lymphocyte count	IPPK KCTD9 FLNB FLT3 IL16 NSD1 TNRC6B BEND3 GPRIN3 PTPN22 ITGA1 ZNF469 TENM4 NRXN2 NFIA PRF1 AGBL2 CORO7	3.79e-03	1464	180	18	EFO_0004587
Disease	Retinitis Pigmentosa	SPATA7 ABCA4 IRX5 SNRNP200	3.83e-03	104	180	4	C0035334
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	FLT3 PTPN22 OS9 PLCL1 PRDX5	3.97e-03	170	180	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	phospholipids in large LDL measurement	ANKRD31 ITGA1 CELSR2	4.18e-03	53	180	3	EFO_0022174
Disease	Schizoaffective disorder-bipolar type	MYT1 NRXN3	4.20e-03	16	180	2	EFO_0009965
Disease	Abnormal behavior	KDM3B DLL1	4.20e-03	16	180	2	C0233514
Disease	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	WDHD1 LRIG1 MTCL1	4.41e-03	54	180	3	EFO_0000180, EFO_0003100, GO_0061479
Disease	alcohol dependence measurement	PODXL NRXN3 DBX1	4.64e-03	55	180	3	EFO_0007835
Disease	retinal vasculature measurement	RAB11FIP2 HIPK2 MCM2 ITGA1 MEF2C LUZP1 CDCA2 FRY PLCL1	4.64e-03	517	180	9	EFO_0010554
Disease	body weight	IPPK MPP2 CUX2 HIVEP2 SPOCK1 TNRC6B ADAMTSL3 MEX3C SP8 NRXN3 FBN2 ANAPC10 MAST4 KCND3 LTBP1 PLCL1	4.65e-03	1261	180	16	EFO_0004338
Disease	respiratory symptom change measurement, response to placebo	BBS9 CDCA2	4.74e-03	17	180	2	EFO_0008344, EFO_0010068
Disease	Acute myeloid leukemia	FLT3 JAK2	4.74e-03	17	180	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	FLT3 JAK2	4.74e-03	17	180	2	601626
Disease	hip circumference	BMS1 ADAMTSL3 PLEKHM1 CDCA2 NRXN3 ANAPC10 NOTCH4	4.87e-03	338	180	7	EFO_0005093
Disease	response to statin	ABCB5 ID4 CELSR2	4.88e-03	56	180	3	GO_0036273
Disease	urate measurement, bone density	MPP2 CRACR2A PODXL ABCB5 PRSS55 MEX3C MAST4 A2ML1 KIAA1755 NOTCH4	4.89e-03	619	180	10	EFO_0003923, EFO_0004531
Disease	total lipids in large LDL	ANKRD31 ITGA1 CELSR2	5.13e-03	57	180	3	EFO_0022163
Disease	cholesterol in large LDL measurement	ANKRD31 ITGA1 CELSR2	5.13e-03	57	180	3	EFO_0021901
Disease	noggin measurement	HIVEP2 MEF2C	5.31e-03	18	180	2	EFO_0021995
Disease	Noonan-Like Syndrome With Loose Anagen Hair	RASA1 A2ML1	5.91e-03	19	180	2	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	RASA1 A2ML1	5.91e-03	19	180	2	C1843181
Disease	Cardio-facio-cutaneous syndrome	RASA1 A2ML1	5.91e-03	19	180	2	C1275081
Disease	Costello syndrome (disorder)	RASA1 A2ML1	5.91e-03	19	180	2	C0587248
Disease	response to cranial radiation therapy, short-term memory	MPP2 NRXN3 DBX1	5.92e-03	60	180	3	EFO_0004335, EFO_0010950

Protein segments in the cluster

Peptide	Gene	Start	Entry
LRNSGLDPNTSKDGL	CSMD3	401	Q7Z407
EGQSLTLSPRLKCNG	CNTLN	1371	Q9NXG0
AGLKENCQAELSPAA	CRYBG3	901	Q68DQ2
ADVLLNKPGFGNRCL	ABCA4	1431	P78363
AGSAAAPCLERAGQK	BHLHE41	196	Q9C0J9
RSQEGKKPDTCEGNL	ABCB5	1001	Q2M3G0
RKPNLGLKSCDGNQE	BAZ1B	1036	Q9UIG0
GGCNTKAARPLISSA	COQ3	21	Q9NZJ6
KGNFRPNGEAKSELC	GRM4	876	Q14833
PDKCRNLSGQTDKTG	A2ML1	276	A8K2U0
DGNFLKLPDTDCRQT	B3GALT5	41	Q9Y2C3
QLLDGGFEQPLSKCS	CRACR2A	481	Q9BSW2
AANVLTKPCGLQRGD	ACSM4	101	P0C7M7
CGADGTLKTRVLPNA	DMXL2	3011	Q8TDJ6
QSCKLAQAPGLRAGE	CELSR2	146	Q9HCU4
SSCGRFDITIGPKQN	AP3M1	286	Q9Y2T2
GDKVNFTLCSGPRLE	CUX2	286	O14529
GSKAGLSPANCQSDR	BMS1	546	Q14692
GCNLNSSFKGSDLPE	BICC1	866	Q9H694
ACPQTSKAAGLSRGL	C3orf22	126	Q8N5N4
GGKQFILQCDSDPEL	GRK2	626	P25098
FCRKIAEGAQQGDPL	NAGK	216	Q9UJ70
AKESQQGCRGLQAPL	NKD1	406	Q969G9
DGERLVKSPQCSNPG	NFIA	146	Q12857
KCLLAASPENEAGGL	RBM28	391	Q9NW13
GPRLNVCDKSSASIG	NSD1	1231	Q96L73
DGGDIINALCFSPNR	RACK1	231	P63244
GLQAFCNLRKSSPGT	RASA1	571	P20936
SLRCQGKNTPERSGL	IPPK	301	Q9H8X2
ICSGGDKPLSALDSQ	JAK2	746	O60674
CRGSLNEAEAGALPA	ITPKC	6	Q96DU7
AEQKAASGCERLQGP	IRX5	221	P78411
ENSPRRGGSFLCDQK	MTCL1	1276	Q9Y4B5
RNAICSGPGELQVKD	MTCL1	1611	Q9Y4B5
DLGSLLFEGCSNSKP	PTPN22	416	Q9Y2R2
LGPGDCAQARKNFSV	PRRX2	26	Q99811
DINVLLCGDPGTAKS	MCM2	516	P49736
NCSGSLGKKQLDPSR	BEND3	596	Q5T5X7
QNGSDCTLDGFPKSR	ANKRD31	1521	Q8N7Z5
AQDKCGIRLASVPGS	PODXL	391	O00592
NSGKTPLDLACEFGR	CASKIN1	146	Q8WXD9
FSPGKSRGLDSQQCA	C22orf46	96	C9J442
EGASLKLCNFEDPSG	KCTD9	286	Q7L273
SSLNLKADDGLRPNC	KCND3	591	Q9UK17
GVICKDQRLPGFSDS	LOXL3	141	P58215
DTKGSLENHCTGNPR	HIPK2	951	Q9H2X6
CSRPLLDLASDQGQG	LRP12	791	Q9Y561
NCSSRGDTPVLDKGQ	MAPK8IP3	861	Q9UPT6
SQLSVLPAAGCRKDG	LRIG1	776	Q96JA1
NGKLACTRENDPIQG	SPINK5	376	Q9NQ38
NGKLFCTRENDPVRG	SPINK5	641	Q9NQ38
ANEGPSLGNRACTKP	KIAA1755	326	Q5JYT7
TRGLKAATCINPLNG	ATRN	901	O75882
AGKGTQAPRLAENFC	AK2	26	P54819
LGRQQASSQCPGDSK	FAM184B	761	Q9ULE4
SPDGQQLATVCKDGR	CORO7	646	P57737
RQCGIPFGAEDSKDQ	HMGXB3	1016	Q12766
QDGKALGALVDSCAP	FLNB	166	O75369
EQGNCSTRRKDSNGP	PCNX1	106	Q96RV3
ARPQLDGESCGAQAL	FHIP2B	211	Q86V87
AFPKNRIIGSGCNLD	LDHAL6B	201	Q9BYZ2
SQCGKALPGLSKQED	LTBP1	566	Q14766
DDLLGTCDQAPKSGS	PRF1	491	P14222
ITGDCNNRRKPALGA	LPO	141	P22079
SSGGCREQTLPTKLN	DBX1	246	A6NMT0
QDGKALGALVDNCAP	FLNC	186	Q14315
SSPSKNRGLCNGNLV	FGF14	31	Q92915
LSQQLDCPAGKAAGT	IL16	176	Q14005
NLPKLVASRDGFQGC	NRXN2	1051	Q9P2S2
PKLVASRDGFQGCLA	NRXN3	1006	Q9Y4C0
QGCLASVDLNGRLPD	NRXN3	1016	Q9Y4C0
QCLQGSGPAREDLFK	NOD1	566	Q9Y239
LKQSGEPFLQDGSCI	KDM3B	891	Q7LBC6
GCAQGISPSDLVRKA	LHX5	66	Q9H2C1
LAGALDKDEGQASPC	LHX6	31	Q9UPM6
ETLRKKGLNGCDSPD	MEF2C	86	Q06413
SLIPCKEAGLRFNAG	MPP2	266	Q14168
QSCGLFPTLGGKRNE	HOXA10	76	P31260
GSQADCELGNPFKRN	ITGA6	771	P23229
NSLQKEPDGEGLLCR	RFPL4A	36	A6NLU0
PGCLLTSGEAEQQRK	GNA13	16	Q14344
DPAGAVNKQGDSILC	ID4	146	P47928
ENKNEPCGARFGTAI	ITGA1	561	P56199
GLANLASGCPDKVRT	MROH1	1386	Q8NDA8
ETLLGALSQCPKGSA	POM121L12	176	Q8N7R1
RLSAIAGNKINCGPA	ARHGAP32	221	A7KAX9
SGKSNLTVLREPECG	ITGB5	701	P18084
KGGRLCLSTDAAAPQ	BBS9	821	Q3SYG4
LEDCASRNRKQGLDP	KLC2	471	Q9H0B6
SSANIGPFLEKRGCI	NCOA4	171	Q13772
KALNVEPDGTGLTCS	PRDX5	191	P30044
SRKSFPCEQKGLDNG	FLT3	386	P36888
VQNGLRPKCDDQGSA	GASK1B	396	Q6UWH4
AKDCSQERGGSPLIL	DUOXA2	286	Q1HG44
CKPGFGVDQLRDDNL	ANAPC10	36	Q9UM13
LGKSTALNCSVDGNP	IGSF10	2351	Q6WRI0
LCDFGSAKQLVRGEP	GSK3A	261	P49840
SNRTLDGKDKAGLCP	CEP43	231	O95684
RDTKCQPQGSSGEEK	DLL1	661	O00548
ALCGKPDQIEGSLAA	FAM20C	376	Q8IXL6
EVKSCDDFLGQLPNG	CR1L	346	Q2VPA4
PKGNRGDSIDQCALI	COL6A3	2366	P12111
SSKEAGCRPLGQLDS	GDF5-AS1	141	Q5U4N7
LCAKGQSAQARLPRG	DNAAF8	481	Q8IYS4
NPQCLLNGSLGEKDD	AGBL2	51	Q5U5Z8
GKKAANGLEADNSCP	LUZP1	581	Q86V48
NLGNFCSPSRKERGA	HOXC11	6	O43248
SPACQAGLKAGDLIT	MAST4	1181	O15021
RKEGLSACQQSGFPA	CDCA2	181	Q69YH5
SRGLPDANDLCLGLQ	CPEB1	86	Q9BZB8
QPRLALNCVGGKSST	MECR	256	Q9BV79
TKGCQRLAAQGARPE	EGLN2	101	Q96KS0
LSLCGQEVGLSKNPS	FRY	2401	Q5TBA9
PLNGCGTIRKVEDQS	CUZD1	321	Q86UP6
GFKLSPNGACVDRNE	FBN2	1881	P35556
KLCGAGEPDQLAQRL	GRIK4	891	Q16099
ELNGVSLIPKGSRDC	GTF2IRD1	216	Q9UHL9
RPALLCKNANGFSGA	GPRIN3	36	Q6ZVF9
GDGKLPCRSNTFLNI	GRM1	861	Q13255
DNKIRLQEGPTSCSG	CD163	926	Q86VB7
DQNIPGLCSDLAKGA	HOXA7	86	P31268
RDCGTSVPQGLLKAA	LRRC40	21	Q9H9A6
LGKFTVNLSGCPRNS	MCMBP	386	Q9BTE3
PRVQSGCDKEALLTG	RNF180	141	Q86T96
VPGNEARLKAFSTCG	OR52L2P	246	Q8NGH6
SDFGTSKRLAGINPC	MAP3K5	821	Q99683
FSQEPRKNCSLGALD	PLEKHM1	481	Q9Y4G2
NSLQKEPDGEGLLCR	RFPL4AL1	36	F8VTS6
PSLCKLGLQEGSNNS	SPAG5	51	Q96R06
IVSQNPGELSCKRGD	SH3D19	426	Q5HYK7
SNGLPRCKSEGTLID	SH3BP4	11	Q9P0V3
CKLDSSGGAVQLPDT	SH3BP4	321	Q9P0V3
SRNKNGPALGGLSCS	MEX3C	306	Q5U5Q3
DLVCLGGSRAQEQKP	RNF215	236	Q9Y6U7
GELKLEEASRQPCGQ	SHROOM3	851	Q8TF72
LPGFTGERCQAKLED	NOTCH4	106	Q99466
GNGSKCDLNGRPREA	OS9	176	Q13438
KENLPSLCSUQGLRA	SELENOP	321	P49908
VSKDGNGALPLNLTC	SLC6A7	171	Q99884
NCQEAERLGPAGASL	SP8	336	Q8IXZ3
CELGNRGSKNLSQSP	ROBO4	671	Q8WZ75
SDGAKIGNCPFSQRL	CLIC1	16	O00299
KRSATDLCGRNDGNL	CDK5RAP1	531	Q96SZ6
DLCGRNDGNLKVIFP	CDK5RAP1	536	Q96SZ6
TGRSCVLGSNAENKP	ZNF610	106	Q8N9Z0
DLCKLGPNDNDTVRG	SMURF2	116	Q9HAU4
SKGLLPNNSEESGIC	XPR1	426	Q9UBH6
SSIIKDPSNQKCGGR	PLCL1	76	Q15111
LKEASGCPGAERNLL	ZNF431	11	Q8TF32
NSLCNQEKGGLEPRR	USP43	771	Q70EL4
LQLSGLNSPGSCLEK	ZCWPW1	441	Q9H0M4
KSEGSLRECLGRQSP	ZNF2	106	Q9BSG1
NECGKAFVGNSPLLR	ZNF19	276	P17023
LTFDQLALDSPKGCG	RPL18	121	Q07020
PQGTLLDKSSRFCQG	ERVFRD-1	181	P60508
NEDPGNCEGVKRTLS	TRPV1	761	Q8NER1
SQLAAGATDCKFLGP	PROM2	21	Q8N271
SLQGDLPNDKDGSRC	SCAF1	46	Q9H7N4
LSPKSCRATKGQAGD	TMEM247	71	A6NEH6
NLGLLENVCDPSGKT	WDHD1	296	O75717
GKDVLPSSGLCQEAA	ZNF417	176	Q8TAU3
GKSLLGAFIPRCNEE	SPOCK1	326	Q08629
PKENSLILAGGDCQL	THOC6	136	Q86W42
LPGKLELCSDDQGSL	NFATC3	351	Q12968
GNKLLAPVALTCGSD	TENM4	1226	Q6N022
DPEKVEISNGLCGLN	SPATA7	546	Q9P0W8
PLGSQESESCGLRKE	ROS1	2291	P08922
RSDKLNNGGSDSPCD	RAB11FIP2	371	Q7L804
NICSAKNRGPGSAIL	VPS41	836	P49754
QARSEPFCGGSILNK	PRSS55	86	Q6UWB4
LPGSQDCRVNLQGKD	ZNF229	116	Q9UJW7
KCNSGLDARPGFGLQ	ZBTB39	561	O15060
KTGLCQAEGDSRPPQ	ZNF469	1676	Q96JG9
QAALGDQPRDILCGA	SNRNP200	121	O75643
DENLLLCAPTGAGKT	SNRNP200	496	O75643
LKEASGCPGADRNLL	ZNF430	11	Q9H8G1
ANDPDGRECIKGVNT	ZNF528	76	Q3MIS6
ERSSKLGSNAGNKPC	ZNF528	91	Q3MIS6
SDCLLDNLPGIKTSG	TRAPPC9	671	Q96Q05
NPGSGQCEKLSRSVL	ZNF614	231	Q8N883
QSLGSSPSQDRGCKQ	ZNF623	66	O75123
VRQGCASEPKDGLQS	HIVEP2	1496	P31629
LNGPQKQDLCAALRG	ZNF425	116	Q6IV72
ACGPLGRAENQAELL	PRSS16	271	Q9NQE7
SCLQLAKADQGDGPE	UIMC1	581	Q96RL1
KDPDSLAQCGVRDGL	UBQLN3	71	Q9H347
RLPKCVSAFANTEGG	SLFN5	211	Q08AF3
CSPSQLKDDGSIGRD	ZFYVE9	241	O95405
VSSNRNPGDDGCLLK	nan	106	Q8N7P7
SSNRNPEDDGCLLKQ	nan	141	Q8N7P7
VSSNRNPEDDGCLLK	nan	276	Q8N7P7
SSNRDPGEDGCLLKQ	nan	311	Q8N7P7
SNRNPGDDGCLLKQG	nan	391	Q8N7P7
EKLTLPFSNQDGCLG	TNRC6B	1136	Q9UPQ9
DPGKGSCSLVIRDAQ	SIGLEC16	96	A6NMB1
LNLSDELCQGPKASS	ADAMTSL3	796	P82987
AVDRAQPLGFNKCGS	LRP4	1301	O75096
VGDLQKLGTSCPALA	EXD3	466	Q8N9H8
GCPLAARRQKEGSLN	MYT1	916	Q01538